Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in: Radiation Oncology 1/2013

Open Access 01-12-2013 | Research

Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy

Authors: Zhong-Hua Ning, Jin-Ming Mu, Jian-Xue Jin, Xiao-Dong Li, Qi-Lin Li, Wen-Dong Gu, Jin Huang, Yang Han, Hong-Lei Pei

Published in: Radiation Oncology | Issue 1/2013

Login to get access

Abstract

Background

The performance of single arc VMAT (VMAT1) for nasopharyngeal carcinoma (NPC) on the Axesse linac has not been well described in previous studies. The purpose of this study is to assess the feasibility of VMAT1 for NPC by comparing the dosimetry, delivery efficiency, and accuracy with dual arc VMAT (VMAT2), dynamic MLC intensity-modulated radiotherapy (dIMRT), and step-and-shoot intensity-modulated radiotherapy (ssIMRT).

Methods

Twenty consecutive patients with non-metastatic NPC were selected to be planned with VMAT1, VMAT2, dIMRT and ssIMRT using Monaco 3.2 TPS on the Axesse™ linear accelerator. Three planning target volumes (PTVs), contoured as high risk, moderate risk and low risk regions, were set to receive median absorbed-dose (D50%) of 72.6 Gy, 63.6 Gy and 54 Gy, respectively. The Homogeneity Index (HI), Conformity Index (CI), Dose Volume Histograms (DVHs), delivery efficiency and accuracy were all evaluated.

Results

Mean HI of PTV72.6 is better with VMAT1(0.07) and VMAT2(0.07) than dIMRT(0.09) and ssIMRT(0.09). Mean HI of PTV63.6 is better with VMAT1(0.21) and VMAT2(0.21) than dIMRT and ssIMRT. Mean CI of PTV72.6 is also better with VMAT1(0.57) and VMAT2(0.57) than dIMRT(0.49) and ssIMRT(0.5). Mean CI of PTV63.6 is better with VMAT1(0.76) and VMAT2(0.76) than dIMRT(0.73) and ssIMRT(0.73). VMAT had significantly improved homogeneity and conformity compared with IMRT. There was no significant difference between VMAT1 and VMAT2 in PTV coverage. Dose to normal tissues was acceptable for all four plan groups. VMAT1 and VMAT2 showed no significant difference in normal tissue sparring, whereas the mean dose of the parotid gland of dIMRT was significantly reduced compared to VMAT1 and VMAT2. The mean delivery time for VMAT1, VMAT2, dIMRT and ssIMRT was 2.7 min, 3.9 min, 5.7 min and 14.1 min, respectively. VMAT1 reduced the average delivery time by 29.8%, 51.1% and 80.8% compared with VMAT2, dIMRT and ssIMRT, respectively. VMAT and IMRT could all be delivered accurately based on our quality assurance standards.

Conclusions

In the treatment of NPC using the Axesse™ linear accelerator, single arc VMAT has shown superiority to double arc VMAT, dIMRT and ssIMRT in delivery efficiency, without compromise to the PTV coverage. However, there is still room for improvement in terms of OAR sparing.
Appendix
Available only for authorised users
Literature
1.
Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ, Ma J: How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?. Int J Radiat Oncol Biol Phys. 2011, 80: 661-668. 10.1016/j.ijrobp.2010.03.024.CrossRefPubMed
2.
Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, Han J, Wu G: A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. Conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012, 104: 286-293. 10.1016/j.radonc.2012.08.013.CrossRefPubMed
3.
Kim S, Akpati HC, Kielbasa JE, Li JG, Liu C, Amdur RJ, Palta JR: Evaluation of intrafraction patient movement for CNS and head & neck IMRT. Med Phys. 2004, 31: 500-506. 10.1118/1.1644641.CrossRefPubMed
4.
Pan JJ, Zheng BH, Zhang Y, Chen CB, Li JL, Zhang X, Pan JJ, Zheng BH, Zhang Y, Chen CB, Li JL, Zhang XC: Measurement of setup error in conformal radiotherapy for nasopharyngeal carcinoma. Ai Zheng. 2006, 25: 115-118.PubMed
5.
Mu X, Lofroth PO, Karlsson M, Zackrisson B: The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimisation problem. Radiother Oncol. 2003, 68: 181-187. 10.1016/S0167-8140(03)00165-8.CrossRefPubMed
6.
Zheng XK, Chen LH, Wang WJ, Ye F, Liu JB, Li QS, Sun HW: Impact of prolonged fraction delivery times simulating IMRT on cultured nasopharyngeal carcinoma cell killing. Int J Radiat Oncol Biol Phys. 2010, 78: 1541-1547. 10.1016/j.ijrobp.2010.07.005.CrossRefPubMed
7.
Wang JZ, Li XA, D’Souza WD, Stewart RD: Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys. 2003, 57: 543-552. 10.1016/S0360-3016(03)00499-1.CrossRefPubMed
8.
Otto K: Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008, 35: 310-317. 10.1118/1.2818738.CrossRefPubMed
9.
Yu CX, Tang G: Intensity-modulated arc therapy: principles, technologies and clinical implementation. Phys Med Biol. 2011, 56: R31-R54. 10.1088/0031-9155/56/5/R01.CrossRefPubMed
10.
Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A: Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011, 84: 967-996. 10.1259/bjr/22373346.CrossRefPubMedPubMedCentral
11.
Lee TF, Ting HM, Chao PJ, Fang FM: Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT. Clin Oncol (R Coll Radiol). 2012, 24: 196-207. 10.1016/j.clon.2011.06.006.CrossRef
12.
13.
RTOG 0615, a phase II study of concurrent chemoradiotherapy using three dimentional conformal radiotherapy (3D-CRT) or intensity-modulated radiation therapy (IMRT) þ bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer. 0615, [http://​www.​rtog.​org/​ClinicalTrials/​ProtocolTable/​StudyDetails.​aspx?​study=​0615], , a phase II study of concurrent chemoradiotherapy using three dimentional conformal radiotherapy (3D-CRT) or intensity-modulated radiation therapy (IMRT) þ bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer
14.
International Commission on Radiation Units and Measurements: Planning Aims: Prescription, and technical data. J ICRU. 2010, 10: 55-59.CrossRef
15.
Cao D, Shepard D: The impact of continuous variable dose rate (CVDR) on VMAT plan quality, delivery efficiency and accuracy [abstract]. Med phys. 2011, 38: 3380-3381.CrossRef
16.
Cosgrove V, Thomas M, Weston S, Thompson M, Reynaert N, Evans C, Brown K, De Wagter C, Thwaites D, Warrington A: Physical characterization of a new concept design of an elekta radiation head with integrated 160-leaf multi-leaf collimator. Int J Radiat Oncol Biol Phys. 2009, 75: S722-S723.CrossRef
17.
Patel I, Glendinning AG, Kirby MC: Dosimetric characteristics of the elekta beam modulator. Phys Med Biol. 2005, 50: 5479-5492. 10.1088/0031-9155/50/23/004.CrossRefPubMed
18.
Bedford J, Thomas M, Smyth G, Warrington A: A pinnacle beam model for the agility 160-leaf multileaf collimator. Radiother Oncol. 2012, 103: S322-CrossRef
19.
Bedford JL, Thomas MD, Smyth G: Beam modeling and VMAT performance with the agility 160-leaf multileaf collimator. J Appl Clin Med Phys. 2013, 14: 172-185.
20.
Schmidhalter D, Fix MK, Niederer P, Mini R, Manser P: Leaf transmission reduction using moving jaws for dynamic MLC IMRT. Med phys. 2007, 34: 3674-3687. 10.1118/1.2768864.CrossRefPubMed
21.
Van Esch A, Huyskens DP, Behrens CF, Samsoe E, Sjolin M, Bjelkengren U, Sjostrom D, Clermont C, Hambach L, Sergent F: Implementing RapidArc into clinical routine: a comprehensive program from machine QA to TPS validation and patient QA. Med phys. 2011, 38: 5146-5166. 10.1118/1.3622672.CrossRefPubMed
22.
Fippel M: Fast monte carlo dose calculation for photon beams based on the VMC electron algorithm. Med phys. 1999, 26: 1466-1475. 10.1118/1.598676.CrossRefPubMed
23.
International Commission on Radiation Units and Measurements: Special considerations regarding absorbed-dose and dose–volume prescribing and reporting in IMRT. J ICRU. 2010, 10: 27-40.
24.
Feuvret L, Noel G, Mazeron JJ, Bey P: Conformity index: a review. Int J Radiat Oncol Biol Phys. 2006, 64: 333-342. 10.1016/j.ijrobp.2005.09.028.CrossRefPubMed
25.
Bertelsen A, Hansen CR, Johansen J, Brink C: Single Arc volumetric modulated Arc therapy of head and neck cancer. Radiother Oncol. 2010, 95: 142-148. 10.1016/j.radonc.2010.01.011.CrossRefPubMed
26.
Fontenot JD, King ML, Johnson SA, Wood CG, Price MJ, Lo KK: Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement. Br J Radiol. 2012, 85: 231-236. 10.1259/bjr/94843998.CrossRefPubMedPubMedCentral
27.
Guckenberger M, Richter A, Krieger T, Wilbert J, Baier K, Flentje M: Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?. Radiother Oncol. 2009, 93: 259-265. 10.1016/j.radonc.2009.08.015.CrossRefPubMed
28.
Zhang DD, Huang SM, Deng XW, Zhang GS: Comparison and evaluation of VMAT and IMRT for the treatment of initial treated nasopharyngeal carcinoma. Chinese J Radiat Oncol. 2012, 21: 364-368.
29.
van Kesteren Z, Janssen TM, Damen E, van Vliet-Vroegindeweij C: The dosimetric impact of leaf interdigitation and leaf width on VMAT treatment planning in pinnacle: comparing pareto fronts. Phys Med Biol. 2012, 57: 2943-2952. 10.1088/0031-9155/57/10/2943.CrossRefPubMed
30.
Lu SH, Cheng JC, Kuo SH, Lee JJ, Chen LH, Wu JK, Chen YH, Chen WY, Wen SY, Chong FC, et al: Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT. Radiother Oncol. 2012, 104: 324-330. 10.1016/j.radonc.2011.11.017.CrossRefPubMed
31.
White P, Chan KC, Cheng KW, Chan KY, Chau MC: Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study. J Radiat Res (Tokyo). 2013, 54: 532-545. 10.1093/jrr/rrs111.CrossRef
32.
Kan MW, Wong W, Leung LH, Yu PK, So RW, Cheng AC: A comprehensive dosimetric evaluation of using RapidArc volumetric-modulated arc therapy for the treatment of early-stage nasopharyngeal carcinoma. J Appl Clin Med Phys. 2012, 13: 189-202.
33.
Wang X, Xiong XP, Lu J, Zhu GP, He SQ, Hu CS, Ying HM: The in vivo study on the radiobiologic effect of prolonged delivery time to tumor control in C57BL mice implanted with lewis lung cancer. Radiat Oncol. 2011, 6: 4-10.1186/1748-717X-6-4.CrossRefPubMedPubMedCentral
34.
Jiang L, Xiong XP, Hu CS, Ou ZL, Zhu GP, Ying HM: In vitro and in vivo studies on radiobiological effects of prolonged fraction delivery time in A549 cells. J Radiat Res (Tokyo). 2012, 54: 230-234.CrossRef
35.
Bertelsen A, Lorenzen EL, Brink C: Validation of a new control system for elekta accelerators facilitating continuously variable dose rate. Med phys. 2011, 38: 4802-4810. 10.1118/1.3615621.CrossRefPubMed
36.
Ghasroddashti E, Smith WL, Quirk S, Kirkby C: Clinical consequences of changing the sliding window IMRT dose rate. J Appl Clin Med Phys. 2012, 13: 3810-PubMed
37.
Vorwerk H, Wagner D, Hess CF: Impact of different leaf velocities and dose rates on the number of monitor units and the dose-volume-histograms using intensity modulated radiotherapy with sliding-window technique. Radiat Oncol. 2008, 3: 31-10.1186/1748-717X-3-31.CrossRefPubMedPubMedCentral
Metadata
Title
Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy
Authors
Zhong-Hua Ning
Jin-Ming Mu
Jian-Xue Jin
Xiao-Dong Li
Qi-Lin Li
Wen-Dong Gu
Jin Huang
Yang Han
Hong-Lei Pei
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2013
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-8-237

Other articles of this Issue 1/2013

Radiation Oncology 1/2013 Go to the issue

Research

Improve definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI

Research

Equivalence of Gyn GEC-ESTRO guidelines for image guided cervical brachytherapy with EUD-based dose prescription

Research

Palliative radiotherapy in patients with a poor performance status: the palliative effect is correlated with prolongation of the survival time

Research

3D-image-guided high-dose-rate intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma

Research

Towards automated on-line adaptation of 2-Step IMRT plans: QUASIMODO phantom and prostate cancer cases

Research

Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy